Literature DB >> 20346265

[IL28 (interferon lambda3) gene polymorphisms and response to IFN-alpha treatment in patients infected with hepatitis virus C].

Dominique Labie1, Hélène Gilgenkrantz.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20346265     DOI： 10.1051/medsci/2010263225

Source DB:  PubMed          Journal:  Med Sci (Paris)        ISSN： 0767-0974            Impact factor:   0.818


× No keyword cloud information.
  3 in total

Review 1.  Interferon lambdas: the next cytokine storm.

Authors:  Christabel Kelly; Paul Klenerman; Eleanor Barnes
Journal:  Gut       Date:  2011-02-08       Impact factor: 23.059

Review 2.  Interferon lambda: a new sword in cancer immunotherapy.

Authors:  Ahmed Lasfar; Walid Abushahba; Murugabaskar Balan; Karine A Cohen-Solal
Journal:  Clin Dev Immunol       Date:  2011-12-06

3.  Single nucleotide polymorphisms of the IL28B and sustained virologic response of patients with chronic hepatitis C to PEG-interferon/ribavirin therapy: A meta-analysis: Meta-analysis of IL28B.

Authors:  Shiying Li; Peng Hu; Qin-Qin Zhang; Ying-Hong Liu; Huai-Dong Hu; Da-Zhi Zhang; Hong Ren
Journal:  Hepat Mon       Date:  2011-03       Impact factor: 0.660
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.